bioLIVE to Merge with BioProduction Congress for 2019 Event

Nov 05, 2018
By Pharmaceutical Technology Editors

On Nov. 5, 2018, bioLIVE,the bioprocessingand manufacturing event running adjacent to CPhI Worldwide, announced that it will merge with BioProduction Congress for its2019 event. The exhibition will continue under the bioLIVE brand. 

The 2019 edition will take place at the Messe Centre in Frankfurt, Germany, on November 5–7, 2019, with bioLIVE continuing to offer a free-to-attend, top-level conference and the bioLIVE insight briefings. However, BioProduction Congress will also be available to attendees on a ‘paid-for’ basis. The agenda will feature a mixture of practical case studies across upstream and downstream manufacturing, a scientific poster hall featuring unpublished peer-review research, and insights on topics ranging from facilities construction to smart factories and bioanalysis.

According to Informa, organizer of both events, the merger of the brands aims to further cement integration across small- and large-molecule industries.

“It was a natural evolution of both platforms to bring their collective [unique selling propositions] together for the benefit of our exhibitors and attendees. BioProduction Congress has built an incredibly robust reputation for content from global thought leaders and CPhI and bioLIVE offer huge audiences and integration with the small-molecule industry,” commented Howard Choi, senior marketing manager, Life Sciences, Informa, in a company press release.  

BioProduction Congress attracts more than 500 global mammalian and microbial experts working across upstream and downstream processing, and bioLIVE 2019 is expected to see more than 2000 attendees, including 1500 delegates and visitors. Collectively, the new event will provide a comprehensive line-up of educational sessions and biopharma industry solution providers.

Adding BioProduction Congress will strengthen our audiences at both CPhI Worldwide and bioLIVE by bringing in scientists and engineers from across the biologics sector,” said Orhan Caglayan, brand director, CPhI Worldwide, in the release. “This will further integrate all parts of the supply chain and development for both small- and large-molecule industries. bioLIVE 2019 will attract a highly qualified audience of more than 1500 biopharma decision makers, as well as global mammalian and microbial scientists actively seeking manufacturing technologies and services to accelerate their biologics and novel molecules towards commercial success."

bioLIVE and BioProduction Congress will feature exhibition platforms, which collectively include more than 60 exhibitors from global contract manufacturing organizations and contract research organizations to equipment manufacturers, biotechs, and supplier companies. The combined event will use the BioProduction Congress partneringONE platform, a proprietary partnering tool that helps identify qualified leads and makes pre-scheduling of onsite meetings far easier, bioLIVE reports.

Source: bioLIVE

native1_300x100
lorem ipsum